← Signals · Technology · TSXV
$NSCI
Nanalysis Scientific Corp.
Signal as of N/A  ·  90-day rolling window  ·  Hardware & Equipment
Confluence Score
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 20–39 have historically hit 47% of the time (avg +6.8% over 90 days, 105 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
Confluence Score
Insider Activity (90d)
9
2 buyers  ·  $60K  ·  open-market only
Current Price
$0.12
CAD  ·  5-min cache
Market Cap
$17M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Technology on Form55: 53% hit rate · -6.0% alpha vs XIU.TO · 19 closed signals Track Record →
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSXV:NSCI
Insider Transactions
90-day window  ·  12 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Jul 02, 2026 Kury, Heather Comp. Grant Buy 100,000
Jun 23, 2026 Maas, Werner E. Open Market Sell 350,000 $0.15 $52K
Jun 23, 2026 Maas, Werner E. Open Market Sell 175,000 $0.20 $35K
Jun 23, 2026 Maas, Werner E. Comp. Grant Buy 167,000 $0.15 -16.7%  · 19d $25K
Jun 23, 2026 Ladd, Jonathan W. Open Market Sell 533,334 $0.15 $80K
Jun 23, 2026 Ladd, Jonathan W. Comp. Grant Buy 167,000 $0.15 -16.7%  · 19d $25K
Jun 23, 2026 Feick, Steven Comp. Grant Buy 167,000 $0.15 -16.7%  · 19d $25K
Jun 23, 2026 Ladd, Jonathan W. Open Market Sell 266,667 $0.20 $53K
May 01, 2026 Maas, Werner E. Other Sell
May 01, 2026 Ladd, Jonathan W. Other Sell
May 01, 2026 Feick, Steven Other Sell
May 01, 2026 Burian, Martin Andrew Comp. Grant Buy 170,000
Score uses open-market buys only  ·  0 open-market  ·  5 plan / compensation shown but not scored  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 25 30 2 unique buyers
Buy/sell ratio 20 90% buys (9B / 1S)
Dollar value 25 $60K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 0 100
Unlock Component Detail — CAD $29/mo
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for NSCI.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Jun 15, 2026
Shares short
189
Net change
-689 (-78.5%)
History
Jun 15: 189
May 31: 878
May 15: 12,235
Apr 30: 34,814
Apr 15: 36,163
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Boardroom Connections
4 insiders also active elsewhere
Insider Other boards Also an insider at
Burian, Martin Andrew 3 ELC (45), LIT, BSK
Stubbs, Jennifer 1 FLNT (55)
Cloetens, Guido 1 ELC (45)
Okoniewski, Michal 1 AXE (55)
People who file as insiders here and at other TSX/TSXV companies (number in brackets = that company's Confluence Score). A well-connected insider taking a seat at a new junior can be an early tell. Matched by name across SEDI filings; funds and 10%+ holders excluded.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.